INCA036978

· Incyte Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INCA036978, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of INCA036978 in Participants With Myeloproliferative Neoplasms [Phase 1]